OncXerna Therapeutics Employee Directory

Biotechnology ResearchMassachusetts, United States11-50 Employees

OncXerna Therapeutics is a clinical stage precision medicine oncology company developing novel therapies to treat solid tumors. Utilizing its innovative precision medicine platform (Xerna™), OncXerna leverages artificial intelligence technologies and RNA expression-based biomarkers to match a specific patient’s tumor with the drugs best suited to treat that tumor. By integrating the Xerna Platform with our deep expertise in clinical development, we believe we can accelerate the development, approval and commercialization of drug product candidates and bring meaningful new treatments to patients as soon as possible.  OncXerna’s lead product candidate, navicixizumab, is a bispecific antibody that inhibits both DLL4 and VEGF and is currently being studied in ovarian cancer, triple negative breast cancer, and colorectal cancer. Another product candidate, bavituximab, is an antibody designed to reverse immune suppression by inhibiting phosphatidylserine signaling and is currently in Phase 2 clinical trials. Navicixizumab and bavituximab are investigational agents that have not been approved and have not been demonstrated to be safe or effective for any use.

Find OncXerna Therapeutics employees' phone numbers or email addresses

OncXerna Therapeutics Global Highlights

North America
5

United States Of America
4
Canada
1

Africa
1

Madagascar
1

Asia
1

Russian Federation
1

Europe
1

France
1

OncXerna Therapeutics's Leadership

C. E.
Chief Financial Officer
Mobile Phone
Email
K. C.
Vice President Clinical Development
Mobile Phone
Email
C. H.
Head Of Legal
Mobile Phone
Email
S. G.
Senior Director, Global Clinical Operations
Mobile Phone
Email

Contact profiles from OncXerna Therapeutics

Name

Title

Contact Info

Location

Last Update

C. E.
Chief Financial Officer
Mobile Phone
Email
Oct 22, 2024
C. H.
Head Of Legal
Mobile Phone
Email
United StatesMassachusetts
Oct 18, 2024
K. C.
Vice President Clinical Development
Mobile Phone
Email
Jul 29, 2024
S. G.
Senior Director, Global Clinical Operations
Mobile Phone
Email
United StatesNorth Carolina
Oct 23, 2024

Frequently Asked Questions

What is OncXerna Therapeutics known for?

OncXerna Therapeutics was founded in 2018 operates in the Biotechnology Research industry. The company's main headquarters is located in 300 5th Ave Suite 6040 Waltham, Massachusetts 02451 US; you can contact the main corporate office by phone at

+1-781-907-****

. Explore OncXerna Therapeutics's company overview page for more information.

What is OncXerna Therapeutics's most common email format?

OncXerna Therapeutics employees' email format typically follows the pattern of . Trying to find reliable and up-to-date employee contact data? Find more OncXerna Therapeutics email formats with LeadIQ.

How many employees does OncXerna Therapeutics have currently?

OncXerna Therapeutics has approximately 11 employees as of July 2025. These team members are located across 4 continents, including North AmericaAfricaAsia.

Who are OncXerna Therapeutics's key employees and leadership?

As of July 2025, OncXerna Therapeutics's key employees include:

Chief Financial Officer: C. E.
Vice President Clinical Development: K. C.
Head Of Legal: C. H.
Senior Director, Global Clinical Operations: S. G.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

Everything for prospecting,
in one platform.

What you can expect from LeadIQ:

B2B data verified in real-time
Sync data to your CRM, & add it to an outreach sequence in one click
Integrations with your tech stack for optimal efficiency
A patented AI cold email generator
Account & contact-level job change tracking